Trial Profile
A Double-Blind, 3-Part Crossover Study to Assess the Pharmacokinetics and Tolerability of Single Doses of Gabapentin Enacarbil and Morphine Administered Alone and in Combination in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2023
Price :
$35
*
At a glance
- Drugs Gabapentin enacarbil (Primary) ; Morphine
- Indications Pain; Restless legs syndrome
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; XenoPort
- 15 Jul 2013 Lead trial centre amended as reported by ClinicalTrials.gov.
- 24 Nov 2011 New trial record